Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.45 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.43 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.38 |
| ▸ | SYK | P43405 | 5/20 | 0.38 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.37 |
| ▸ | LOX | P28300 | 1/20 | 0.37 |
| ▸ | IDH1 | O75874 | 3/20 | 0.36 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.36 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.36 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.36 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.36 |
| ▸ | HTR2C | P28335 | 3/20 | 0.36 |
| ▸ | HTR2A | P28223 | 2/20 | 0.36 |
| ▸ | HTR2B | P41595 | 2/20 | 0.36 |
| ▸ | IDH2 | P48735 | 2/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26294995 | 0.83 | IDH1 (0.33) | TRPV4ADRB1SYKIDH1IDH2 | |
| SCHEMBL8751966 | 0.83 | TRPV4 (0.33) | TRPV4ADRB1 | |
| SCHEMBL31525410 | 0.77 | SYK (0.38) | SYK | |
| SCHEMBL27285543 | 0.74 | ADRB1 (0.44) | TRPV4ADRB1LOXL2SYKTAS2R14 | |
| SCHEMBL3295825 | 0.74 | MALT1 (0.47) | TRPV4ADRB1LOXL2SYKTAS2R14 | |
| SCHEMBL1337601 | 0.73 | ADRB1 (0.43) | TRPV4ADRB1LOXL2SYKTAS2R14 | |
| SCHEMBL17049228 | 0.73 | ADRB1 (0.43) | TRPV4ADRB1LOXL2SYKTAS2R14 | |
| SCHEMBL171691 | 0.73 | ADRB1 (0.43) | ADRB1LOXL2SYKTAS2R14LOX | |
| SCHEMBL2873952 | 0.73 | ADRB1 (0.43) | TRPV4ADRB1LOXL2SYKTAS2R14 | |
| SCHEMBL17959 | 0.73 | GABRA1 (0.50) | ADRB1LOXL2SYKTAS2R14LOX |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115515998-B | Synthesis of polyurethanes by chain growth copolymerization | 伊夫·雅努 | 2025-06-24 | — | — | CN | claimed |
| CN-118704008-A | Copper etching solution for packaging circuit substrate and preparation method and application thereof | 浙江奥首材料科技有限公司 | 2024-09-27 | — | — | CN | claimed |
| CN-116603117-B | Super-hydrophobic drug structure coating with drug release performance and preparation method thereof | 四川大学华西医院 | 2023-10-13 | — | — | CN | claimed |
| CN-116603117-A | Super-hydrophobic drug structure coating with drug release performance and preparation method thereof | 四川大学华西医院 | 2023-08-18 | — | — | CN | claimed |
| US-20230242699-A1 | POLYCARBAMATE SYNTHESIS VIA CHAIN-GROWTH COPOLYMERIZATION | FENG, Xiaoshuang (CN) | 2023-08-03 | — | — | US | claimed |
| EP-4146716-A1 | POLYCARBAMATE SYNTHESIS VIA CHAIN-GROWTH COPOLYMERIZATION | King Abdullah University Of Science And Technology (SA) | 2023-03-15 | — | — | EP | claimed |
| CN-115515998-A | Synthesis of polyurethanes by chain-growth copolymerization | 阿卜杜拉国王科技大学 | 2022-12-23 | — | — | CN | claimed |
| EP-3686203-A1 | 4-SULFUR SUBSTITUTED PODOPHYLLOTOXIN DERIVATIVE AND PREPARATION METHOD THEREFOR AND USE THEREOF | Tang, Yajie (CN) | 2020-07-29 | — | — | EP | claimed |
| CN-111454308-A | Teniposide derivative and preparation method and application thereof | 湖北工业大学 | 2020-07-28 | — | — | CN | claimed |
| US-20200216462-A1 | 4-Sulfur Substituted Podophyllotoxin Derivative and Preparation Method Therefor and Use Thereof | Tang, YaJie (CN) | 2020-07-09 | — | — | US | claimed |
| US-20200216449-A1 | 4-Sulfur Substituted Podophyllotoxin Derivative and Preparation Method Therefor and Use Thereof | Tang, YaJie (CN) | 2020-07-09 | — | — | US | claimed |
| CN-108285456-A | 4- sulphur replaces podophyllotoxin derivative and its preparation method and application | 汤亚杰 | 2018-07-17 | — | — | CN | claimed |
| CN-102391424-B | Method for modifying styrene-butadiene-styrene (SBS) block copolymer | UNIV SHANGHAI JIAOTONG | 2013-02-27 | — | — | CN | claimed |
| CN-102391424-A | Method for modifying styrene-butadiene-styrene (SBS) block copolymer | UNIV SHANGHAI JIAOTONG | 2012-03-28 | — | — | CN | claimed |
| EP-1069211-A2 | Electroplating solutions | THE BOC GROUP, INC. (US) | 2001-01-17 | — | — | EP | claimed |
| US-12613191-B2 | Multiplexed Raman molecular imaging | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2026-04-28 | — | — | US | disclosed |
| CN-115515998-B | Synthesis of polyurethanes by chain growth copolymerization | 伊夫·雅努 | 2025-06-24 | — | — | CN | disclosed |
| US-6531470-B1 | Antimicrobial compounds | PHARMACIA & UPJOHN COMPANY | 2003-03-11 | — | — | US | disclosed |
| CN-1288462-A | Oxazolidinone combinatorial libraries, compositions and method of prepn. | UPJOHN CO (US) | 2001-03-21 | — | — | CN | disclosed |
| EP-1069211-A2 | Electroplating solutions | THE BOC GROUP, INC. (US) | 2001-01-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12613191-B2 | Multiplexed Raman molecular imaging | FABP1, SCNN1G, VIL1 | TRPV4 552/4885ADRB1 1243/4885LOXL2 800/4885 |
| US-20200216462-A1 | 4-Sulfur Substituted Podophyllotoxin Derivative and Preparation Method Therefor and Use Thereof | WEE1, WEE2, DHFR | TRPV4 863/4885ADRB1 4016/4885LOXL2 1646/4885 |
| US-20200216449-A1 | 4-Sulfur Substituted Podophyllotoxin Derivative and Preparation Method Therefor and Use Thereof | TPMT, WEE1, DHFR | TRPV4 869/4885ADRB1 4018/4885LOXL2 1816/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.